PRELUDE CAPITAL MANAGEMENT, LLC - UNIQURE NV ownership

UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of UNIQURE NV
ValueSharesWeighting
Q3 2023$84,103
-38.9%
12,534
+4.4%
0.01%
-44.4%
Q2 2023$137,623
-31.9%
12,009
+100.2%
0.01%
+80.0%
Q1 2021$202,000
-6.9%
6,0000.0%0.01%
-16.7%
Q4 2020$217,000
+119.2%
6,000
+122.2%
0.01%
+20.0%
Q3 2020$99,000
-24.4%
2,700
-6.9%
0.01%
-28.6%
Q2 2020$131,000
+13000.0%
2,900
+16011.1%
0.01%
Q4 2019$1,000
-90.0%
18
-98.2%
0.00%
-100.0%
Q3 2017$10,000
-23.1%
992
-56.9%
0.00%
-50.0%
Q4 2016$13,000
-61.8%
2,300
-48.9%
0.00%
-50.0%
Q3 2016$34,000
+126.7%
4,500
+114.3%
0.00%
+100.0%
Q2 2016$15,000
-58.3%
2,100
-30.0%
0.00%
-60.0%
Q1 2016$36,000
+80.0%
3,000
+150.0%
0.01%
+66.7%
Q4 2015$20,000
-51.2%
1,200
-40.0%
0.00%
-50.0%
Q3 2015$41,000
-56.8%
2,000
-42.9%
0.01%
-53.8%
Q2 2015$95,000
+21.8%
3,500
+9.4%
0.01%
+18.2%
Q1 2015$78,0003,2000.01%
Other shareholders
UNIQURE NV shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 841,471$15,786,0005.69%
Nantahala Capital Management 2,901,929$54,440,0003.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 544,500$10,209,0003.27%
683 Capital Management, LLC 1,373,600$25,768,0001.99%
PFM Health Sciences, LP 2,393,311$44,899,0001.62%
Integral Health Asset Management, LLC 433,000$8,123,0001.58%
Privium Fund Management B.V. 238,998$4,283,0001.56%
Nantahala Capital Management 1,000,000$18,760,0001.21%
Henry James International Management Inc. 89,469$1,678,0000.94%
Altium Capital Management LP 105,000$1,970,0000.72%
View complete list of UNIQURE NV shareholders